Flumazenil to reverse sedation during depression treatment
Treatments studied
Part of Mental health clinical trials.
This trial tests whether flumazenil (a medication that reverses sedation from anti-anxiety drugs) can safely help patients wake up faster after electroconvulsive therapy (ECT), a treatment for severe depression. The goal is to see if it improves recovery time without causing problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with depression (including bipolar depression) and are currently in a depressive episode
- You are admitted to a participating hospital in the Mental Health Services of the Capital Region of Denmark
- Your psychiatrist has referred you for ECT and you have agreed to it
- You are currently taking anti-anxiety medications (like benzodiazepines) or sleeping pills at a minimum dose
- You are voluntarily receiving ECT (not involuntary treatment)
- You can read and understand Danish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
This study tests whether using a virtual reality mindfulness program, added to your usual depression care, can help people whose depression hasn't responded to standard treatments.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.
This trial tests whether two oral medications, ketamine and midazolam, can help treat major depression when taken by mouth. It aims to compare how well each drug works in reducing depressive symptoms.
This trial tests two different medications to quickly calm severe agitation in people admitted to a psychiatric emergency room. You may be able to join if you are extremely agitated and need urgent medication to help you settle down.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.